NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-021-2015-0-SE-46 Anti-CD70 Chimeric Antigen Receptors SE EP 19178931.2 Issued
NCI E-021-2015-0-ES-45 Anti-CD70 Chimeric Antigen Receptors ES EP 19178931.2 Issued
NCI E-021-2015-0-NO-44 Anti-CD70 Chimeric Antigen Receptors NO EP 19178931.2 Issued
NCI E-021-2015-0-NL-43 Anti-CD70 Chimeric Antigen Receptors NL EP 19178931.2 Issued
NCI E-021-2015-0-IT-42 Anti-CD70 Chimeric Antigen Receptors IT EP 19178931.2 Issued
NCI E-021-2015-0-GB-48 Anti-CD70 Chimeric Antigen Receptors GB EP 19178931.2 Issued
NCI E-021-2015-0-CH-47 Anti-CD70 Chimeric Antigen Receptors CH EP 19178931.2 Issued
NCI E-021-2015-0-FR-40 Anti-CD70 Chimeric Antigen Receptors FR EP 19178931.2 Issued
NCI E-021-2015-0-DE-41 Anti-CD70 Chimeric Antigen Receptors DE EP 19178931.2 Issued
NCI E-169-2016-0-EP-05 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS EP National Stage 17 808 241.8 Issued
NCI E-169-2016-0-FR-10 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS FR EP 17 808 241.8 Issued
NCI E-169-2016-0-DE-08 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS DE EP 17 808 241.8 Issued
NCI E-169-2016-0-CH-07 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS CH EP 17 808 241.8 Issued
NCI E-169-2016-0-GB-11 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS GB EP 17 808 241.8 Issued
NCI E-169-2016-0-ES-09 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS ES EP 17 808 241.8 Issued
NCI E-169-2016-0-IT-13 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS IT EP 17 808 241.8 Issued
NCI E-169-2016-0-IE-12 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS IE EP 17 808 241.8 Issued
NCI E-169-2016-0-NL-14 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS NL EP 17 808 241.8 Issued
NINDS E-130-2022-3-US-01 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE US National Stage 16/467,721 Pending
NCATS E-096-2018-0-JP-07 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine JP National Stage 2020-567577 Issued
NCATS E-096-2018-0-CN-05 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine CN National Stage 2019800423897 Issued
NCATS E-096-2018-0-AU-03 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine AU National Stage 2019282560 Issued
NCATS E-096-2018-0-IT-01 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine IT EP 19732189.6 Issued
NCATS E-096-2018-0-DE-01 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine DE EP 19732189.6 Issued
NCATS E-096-2018-0-FR-01 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine FR EP 19732189.6 Issued
NCATS E-096-2018-0-EP-06 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine EP National Stage 19732189.6 Issued
NCATS E-096-2018-0-ES-01 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine ES EP 19732189.6 Issued
NCATS E-096-2018-0-GB-01 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine GB EP 19732189.6 Issued
NCATS E-096-2018-0-PCT-02 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine PCT PCT PCT/US2019/035360 Expired
NCATS E-096-2018-0-CA-04 Process For The Synthesis And Purification Of (2R,6R)-hydroxynorketamine CA National Stage 3102387 Pending
NIA E-061-2019-0-US-01 INHIBITORS OF LRP1-DKK PROTEIN COMPLEX TO PROMOTE CLEARANCE OF AMYLOID-BETA US 62/857,204 Abandoned
NICHD E-039-2016-1-US-06 TREATMENT OF HORMONAL DISORDERS OF GROWTH US CON 16/430,079 Abandoned
NCATS E-091-2016-0-CN-04 COMPOUNDS AND METHOD FOR BLOCKING TRANSMISSION OF MALARIAL PARASITE CN National Stage 201780074074.1 Pending
NIAID E-174-2017-1-MX-05 Protection Of Calves By A Prefusion-stabillze Bovine RSV Vaccine MX National Stage MX/a/2019/006349 Pending
NIBIB E-005-2012-3-CN-08 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS CN National Stage 201880004664.1 Issued
NIAID E-135-2010-0-US-08 GENETICALLY STABLE LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE AND ITS PRODUCTION US CON 16/425,725 10980872 Issued PDF
NEI E-164-2014-0-US-06 METHODS AND COMPOSITIONS FOR TREATING LEBER CONGENITAL AMAUROSIS US DIV 16/423,962 1142-12-19 Issued PDF
NIAID E-145-2011-0-IN-15 Plasmodial Surface Anion Channel Inhibitors For The Treatment Of Prevention Of Malaria IN DIV 201948020664 Issued
NIAID E-076-2019-0-US-01 MAMMALIAN CELL FOR PRODUCING MODIFIED VACCINIA ANKARA (MVA) VIRUS US 62/852,294 Abandoned
NIAID E-191-2018-0-PCT-02 Improved Methods Of Manufacturing Peptide-Based Vaccines PCT PCT PCT/US2019/033612 Expired
NIAID E-191-2018-0-CN-06 Improved Methods Of Manufacturing Peptide-Based Vaccines CN National Stage 201980049152.1 Pending
NIAID E-191-2018-0-EP-07 Improved Methods Of Manufacturing Peptide-Based Vaccines EP National Stage 19734178.7 Pending
NIAID E-191-2018-0-IN-08 Improved Methods Of Manufacturing Peptide-Based Vaccines IN National Stage 202017055861 Pending
NIAID E-213-2021-1-US-01 Aromatic Ring Substituted Amphiphilic Polymers As Drug Delivery Systems US 62/851,523 Abandoned
NIAID E-191-2018-0-CA-05 Improved Methods Of Manufacturing Peptide-Based Vaccines CA National Stage 3104729 Pending
NIAID E-191-2018-0-AU-04 Improved Methods Of Manufacturing Peptide-Based Vaccines AU National Stage 2019272844 Pending
NCATS E-230-2016-2-US-02 Tools To Develop A Therapy For The Treatment Of Zellweger Spectrum Disorder US CON 16/417,167 11065247 Issued PDF
NHGRI E-217-2007-0-US-17 N-ACETYL MANNOSAMMINE AS A THERAPEUTIC AGENT US CON 16/417,488 10953026 Issued PDF
NHLBI E-219-2018-2-PCT-01 A Fully Automated System For Quantitative Myocardial Perfusion Pixel Mapping And Machine Diagnosis To Detect Ischemic Heart Disease With First-pass Perfusion Cardiac Magnetic Resonance Imaging PCT PCT COMB PCT/IB2019/054112 Expired
NHLBI E-219-2018-2-EP-04 A Fully Automated System For Quantitative Myocardial Perfusion Pixel Mapping And Machine Diagnosis To Detect Ischemic Heart Disease With First-pass Perfusion Cardiac Magnetic Resonance Imaging EP National Stage 19803953.9 Abandoned